Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review

References

• ErikssonSPulmonary emphysema and alpha1-antitrypsin deficiencyActa Med Scandinavica1964175197205
   PubMed Web of Science ®Google Scholar
• StockleyRATurnerAMAlpha-1-Antitrypsin deficiency: clinical variability, assessment, and treatmentTrends Mol Med201420210511524380646
   PubMed Web of Science ®Google Scholar
• StockleyRAEdgarRGPillaiATurnerAMIndividualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?Int J Chron Obstruct Pulmon Dis201611174527536086
   PubMed Web of Science ®Google Scholar
• LaurellCBErikssonSThe serum α1-antitrypsin in families with hypo-α1-antitrypsinemiaClin Chim Acta196511539539814347984
   PubMed Web of Science ®Google Scholar
• LaurellC-BErikssonSThe electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. 1963COPD201310Suppl 13823527532
   PubMedGoogle Scholar
• NeedhamMStockleyRAAlpha1-Antitrypsin deficiency.3: clinical manifestations and natural historyThorax200459544144515115878
   PubMed Web of Science ®Google Scholar
• ErikssonSCarlsonJVelezRRisk of cirrhosis and primary liver cancer in alpha1-antitrypsin deficiencyN Engl J Med1986314127367393485248
   PubMed Web of Science ®Google Scholar
• ParrDGGuestPGReynoldsJHDowsonLJStockleyRAPrevalence and impact of bronchiectasis in alpha1-antitrypsin deficiencyAm J Respir Crit Care Med2007176121215122117872489
   PubMed Web of Science ®Google Scholar
• SvegerTLiver disease in alpha antitrypsin deficiency detected by screening of 200,000 infantsN Engl J Med197629424131613211083485
   PubMed Web of Science ®Google Scholar
• BlancoIde SerresFJFernandez-BustilloELaraBMiravitllesMEstimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countriesEur Respir J2006271778416387939
   PubMed Web of Science ®Google Scholar
• LomasDAEvansDLFinchJTCarrellRWThe mechanism of Z alpha1-antitrypsin accumulation in the liverNature199235763796056071608473
   PubMed Web of Science ®Google Scholar
• GreenCEVayalapraSHampsonJAMukherjeeDStockleyRATurnerAMPiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPDThorax2015701093994526141072
   PubMed Web of Science ®Google Scholar
• StockleyRANeutrophils and the pathogenesis of COPDChest20021215151S155S12010844
   PubMed Web of Science ®Google Scholar
• LiouTGCampbellEJQuantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activityJ Immunol19961576262426318805666
   PubMed Web of Science ®Google Scholar
• CampbellEJCampbellMABoukedesSSOwenCAQuantum proteolysis by neutrophils: Implications for pulmonary emphysema in alpha1-antitrypsin deficiencyJ Clin Invest1999104333734410430615
   PubMed Web of Science ®Google Scholar
• StollerJKAboussouanLSA review of alpha1-antitrypsin deficiencyAm J Respir Crit Care Med2012185324625921960536
   PubMed Web of Science ®Google Scholar
• CamposMAAlazemiSZhangGWannerASandhausRAEffects of a disease management program in individuals with alpha-1 antitrypsin deficiencyCOPD200961314019229706
   PubMedGoogle Scholar
• ChapmanKRStockleyRADawkinsCWilkesMMNavickisRJAugmentation therapy for alpha1 antitrypsin deficiency: a meta-analysisCOPD20096317718419811373
   PubMedGoogle Scholar
• GøtzschePCJohansenHKIntravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung diseaseCochrane Database Syst Rev20169CD00785127644166
   PubMed Web of Science ®Google Scholar
• GreenCEParrDGEdgarRGStockleyRATurnerAMLung density associates with survival in alpha 1 antitrypsin deficient patientsRespir Med2016112818726874894
   PubMed Web of Science ®Google Scholar
• DawkinsPWoodANightingalePStockleyRMortality in alpha-1-antitrypsin deficiency in the United KingdomRespir Med2009103101540154719443188
   PubMed Web of Science ®Google Scholar
• JordanREMajothiSHeneghanNRSupported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysisHealth Technol Assess201519361
   Web of Science ®Google Scholar
• KewKMDiasSCatesCJLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisCochrane Database Syst Rev20143CD01084424671923
   PubMed Web of Science ®Google Scholar
• HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]The Cochrane Collaboration2011 Available from: http://handbook.cochrane.orgAccessed June 23, 2015
   Google Scholar
• MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementPLoS Med200967e100009719621072
   PubMed Web of Science ®Google Scholar
• DirksenADijkmanJHMadsenFA randomized clinical trial of alpha1-antitrypsin augmentation therapyAm J Respir Crit Care Med19991605 Pt I1468147210556107
   PubMed Web of Science ®Google Scholar
• DirksenAPiitulainenEParrDGExploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiencyEur Respir J20093361345135319196813
   PubMed Web of Science ®Google Scholar
• ChapmanKRBurdonJGPiitulainenEIntravenous augmentation treatment and lung density in severe alpha1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trialLancet2015386999136036826026936
   PubMed Web of Science ®Google Scholar
• ParrDGDawkinsPAStockleyRAComputed tomography: a new gold standard for the clinical assessment of emphysemaAm J Respir Crit Care Med2006174895417021361
   PubMed Web of Science ®Google Scholar
• ParrDGStoelBCStolkJStockleyRAValidation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiencyThorax200661648549016537666
   PubMed Web of Science ®Google Scholar
• ParrDGDirksenAPiitulainenEDengCWenckerMStockleyRAExploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiencyRespir Res2009107519678952
   PubMed Web of Science ®Google Scholar
• StollerJKFallatRSchluchterMDAugmentation therapy with alpha1-antitrypsin patterns of use and adverse eventsChest200312351425143412740257
   PubMed Web of Science ®Google Scholar
• Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study GroupAm J Respir Crit Care Med1998158149599655706
   PubMed Web of Science ®Google Scholar
• SeersholmNWenckerMBanikNDoes alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency?Eur Respir J19971010226022639387950
   PubMed Web of Science ®Google Scholar
• TonelliARRouhaniFLiNSchreckPBrantlyMLAlpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue BankInt J Chron Obstruct Pulmon Dis2009444345220054436
   PubMedGoogle Scholar
• WenckerMFuhrmannBBanikNKonietzkoNWissenschaftliche Arbeitsgemeinschaft zur Therapie von L. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitorChest2001119373774411243951
   PubMed Web of Science ®Google Scholar
• Barros-TizonJCTorresMLBlancoIMartinezMTInvestigators of the rEXA study groupReduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapyTher Adv Respir Dis201262677822354900
   PubMed Web of Science ®Google Scholar
• CamposMAKueppersFStocksJMSafety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multi-center, randomized, double-blind, crossover study (SPARK)COPD201310668769523862647
   PubMedGoogle Scholar
• StocksJMBrantlyMLWang-SmithLPharmacokinetic comparability of Prolastin-C to Prolastin in alpha1-antitrypsin deficiency: a randomized studyBMC Clin Pharmacol2010101320920295
   PubMedGoogle Scholar
• SandhausRAStocksJRouhaniFNBrantlyMStraussPBiochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous)COPD2014111172523822603
   PubMedGoogle Scholar
• StocksJMBrantlyMPollockDMulti-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, ZemairaCOPD200631172317175661
   PubMedGoogle Scholar
• StollerJKRouhaniFBrantlyMBiochemical efficacy and safety of a new pooled human plasma alpha1-antitrypsin, RespitinChest20021221667412114340
   PubMed Web of Science ®Google Scholar
• BarkerAFSiemsenFPasleyDD’SilvaRBuistASReplacement therapy for hereditary alpha1-antitrypsin deficiency: a program for long-term administrationChest19941055140614108181327
   PubMed Web of Science ®Google Scholar
• SchmidtEWRascheBUlmerWTReplacement therapy for alpha-1-protease inhibitor deficiency in P(i)Z subjects with chronic obstructive lung diseaseAm J Med1988846 A63693289388
   PubMed Web of Science ®Google Scholar
• VidalRBarros-TizonJCGaldizJBTolerance and safety of Trypsone: prospective follow-up in alpha-1 antitrypsin deficient subjects with pulmonary emphysemaMinerva Pneumol20104928391
   Google Scholar
• BarkerAFIwata-MorganIOvesonLRousselRPharmacokinetic study of alpha1-antitrypsin infusion in alpha1-antitrypsin deficiencyChest199711236076139315791
   PubMed Web of Science ®Google Scholar
• WewersMDCasolaroMASellersSEReplacement therapy for alpha 1-antitrypsin deficiency associated with emphysemaN Engl J Med198731617105510623494198
   PubMed Web of Science ®Google Scholar
• WeberDBeckerMKonietzkoNErgebnis einer 18monati gen Substitutionstherapie bei Patienten mit alpha1-Pi-Mangel und Lungenemphysem [Effect of a 18 month replacement therapy in patients with alpha1-antitrypsin deficiency and lung emphysema]Atemwegs-und Lungenkrankheiten19871312567572 German
   Web of Science ®Google Scholar
• SubramanianDRJenkinsLEdgarRQuraishiNStockleyRAParrDGAssessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomographyAm J Respir Crit Care Med2012186111125113222837375
   PubMed Web of Science ®Google Scholar
• MiravitllesMVidalRTorrellaMBofillJMCotrinaMde GraciaJEvaluacion del tratamiento sustitutivo del enfisema por deficit de alfa-1-antitripsina. [Evaluation of replacement therapy in emphysema caused by alpha 1-antitrypsin deficiency]Arch Bronconeumol19943010479484 Spanish7827760
   PubMedGoogle Scholar
• SchwaiblmairMVogelmeierCFruhmannGLong-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency three-year follow-upRespiration199764110159044469
   PubMed Web of Science ®Google Scholar
• WenckerMBanikNBuhlRSeidelRKonietzkoNLangzeittherapie des alpha1-Antitrypsin-Mangelassoziierten Lungenemphysems mit Humanem alpha1-Antitrypsin [Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin]Pneumologie19985210545552 German9847632
   PubMedGoogle Scholar
• CamposMAAlazemiSZhangGClinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 yearsChest2009135360060819017884
   PubMed Web of Science ®Google Scholar
• CamposMAAlazemiSZhangGExacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapyRespir Med2009103101532153919464158
   PubMed Web of Science ®Google Scholar
• CamposMAAlazemiSZhangGSandhausRAWannerAInfluenza vaccination in subjects with alpha1-antitrypsin deficiencyChest20081331495517908701
   PubMed Web of Science ®Google Scholar
• CassinaPCTeschlerHKonietzkoNTheegartenDStamatisGTwo-year results after lung volume reduction surgery in alpha1-antitrypsin deficiency versus smoker’s emphysemaEur Respir J1998125102810329863992
   PubMed Web of Science ®Google Scholar
• DauriatGMalHJebrakGFunctional results of unilateral lung volume reduction surgery in alpha1-antitrypsin deficient patientsInt J Chron Obstruct Pulmon Dis20061220120618046897
   PubMedGoogle Scholar
• FujimotoTTeschlerHHillejanLZabouraGStamatisGLong-term results of lung volume reduction surgeryEur J Cardiothorac Surg200221348348811888768
   PubMed Web of Science ®Google Scholar
• StollerJKGildeaTRRiesALMeliYMKarafaMTLung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiencyAnn Thorac Surg200783124125117184672
   PubMed Web of Science ®Google Scholar
• TuticMBlochKELardinoisDBrackTRussiEWWederWLong-term results after lung volume reduction surgery in patients with alpha(1)-antitrypsin deficiencyJ Thorac Cardiovasc Surg2004128340841315354100
   PubMed Web of Science ®Google Scholar
• HillerdalGMindusSOne-to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case seriesRespiration201488432032825227936
   PubMed Web of Science ®Google Scholar
• BangaAGildeaTRajeswaranJRokadiaHBlackstoneEHStollerJKThe natural history of lung function after lung transplantation for alpha(1)-antitrypsin deficiencyAm J Respir Crit Care Med2014190327428125003824
   PubMed Web of Science ®Google Scholar
• BredahlPZemtsovskiMPerchMEarly laparotomy after lung transplantation: Increased incidence for patients with alpha1-anti-trypsin deficiencyJ Heart Lung Transplant201433772773324709270
   PubMed Web of Science ®Google Scholar
• BreenTJKeckBHosenpudJDO’ConnellJBWhiteRDailyOPThoracic organ transplants in the United States from October 1987 through December 1991: a report from the UNOS Scientific Registry for Organ TransplantsClin Transpl199233431306709
   PubMedGoogle Scholar
• BurtonCMMilmanNCarlsenJThe Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantationJ Heart Lung Transplant200524111834184316297790
   PubMed Web of Science ®Google Scholar
• CassiviSDMeyersBFBattafaranoRJThirteen-year experience in lung transplantation for emphysemaAnn Thorac Surg200274516631669 [Discussion] 1669–167012440627
   PubMed Web of Science ®Google Scholar
• ChristieJDEdwardsLBAuroraPRegistry of the International Society for Heart and Lung Transplantation: Twenty-fifth Official Adult Lung and Heart/Lung Transplantation Report-2008J Heart Lung Transplant200827995796918765187
   PubMed Web of Science ®Google Scholar
• de PerrotMChaparroCMcRaeKTwenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survivalJ Thorac Cardiovasc Surg200412751493150115116013
   PubMed Web of Science ®Google Scholar
• GunesAAboyounCLMortonJMPlitMMaloufMAGlanvilleARLung transplantation for chronic obstructive pulmonary disease at St. Vincent’s HospitalIntern Med J200636151116409307
   PubMed Web of Science ®Google Scholar
• InciISchuurmansMEhrsamJLung transplantation for emphysema: impact of age on short-and long-term survivalEur J Cardiothorac Surg201548690690925602056
   PubMed Web of Science ®Google Scholar
• TanashHARiiseGCHanssonLNilssonPMPiitulainenESurvival benefit of lung transplantation in individuals with severe alpha1-anti-trypsin deficiency (PiZZ) and emphysemaJ Heart Lung Transplant201130121342134721821433
   PubMed Web of Science ®Google Scholar
• StoneHMEdgarRGThompsonRDStockleyRALung transplantation in alpha-1-antitrypsin deficiencyCOPD201613214615226488418
   PubMedGoogle Scholar
• StolkJStockleyRAStoelBCRandomised controlled trial for emphysema with a selective agonist of the gamma-type retinoic acid receptorEur Respir J201240230631222282548
   PubMed Web of Science ®Google Scholar
• International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients with Emphysema2014 Available from: http://ClinicalTrials.gov/show/NCT1217671
   Google Scholar
• StraussPStolkJMcElvaneyGPiitulainenESeersholmNChapmanKRPhase II/III, double-blind, randomized, placebo-controlled, international study evaluating the safety and efficacy of inhaled, human, alpha-1 antitrypsin (AAT) in alpha-1 antitrypsin deficient patients (AATD) (Abstract)Am J Respir Crit Care Med2014 Meeting AbstractsA5790 Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/464/CN-01038464/frame.htmlAccessed April 21, 2015
   Google Scholar
• Pharmacokinetic Study of ARALAST (Human Alpha1- PI)2011 Available from: http://ClinicalTrials.gov/show/NCT0242385
   Google Scholar
• Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects with Alpha1-Antitrypsin Deficiency2013 Available from: http://ClinicalTrials.gov/show/NCT1213043
   Google Scholar
• Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects with Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)2015 Available from: http://ClinicalTrials.gov/show/NCT1983241
   Google Scholar
• SorrellsSCamprubiSGriffinRChenJAyguasanosaJSPARTA clinical trial design: Exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiencyRespir Med2015109449049925727857
   PubMed Web of Science ®Google Scholar
• DowsonLJGuestPJHillSLHolderRLStockleyRAHigh-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health statusEur Respir J20011761097110411491150
   PubMed Web of Science ®Google Scholar
• DowsonLJGuestPJStockleyRALongitudinal changes in physiological, radiological, and health status measurements in alpha1-antitrypsin deficiency and factors associated with declineAm J Respir Crit Care Med200116410 Pt 11805180911734427
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• LeidyNKWilcoxTKJonesPWRobertsLPowersJHSethiSStandardizing measurement of chronic obstructive pulmonary disease exacerbationsAm J Respir Crit Care Med2011183332332920813886
   PubMed Web of Science ®Google Scholar
• WaltersEHWaltersJWillsKERobinsonAWood-BakerRClinical diaries in COPD: compliance and utility in predicting acute exacerbationsInt J Chron Obstruct Pulmon Dis2012742743522848156
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• PillaiAPTurnerAMStockleyRARelationship of the 2011 Global Initiative for Chronic Obstructive Lung Disease Strategy to clinically relevant outcomes in individuals with α1-antitrypsin deficiencyAnn Am Thorac Soc201411685986424950156
   PubMedGoogle Scholar
• AnzuetoALeimerIKestenSImpact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomesInt J Chron Obstruct Pulmon Dis2009424525119657398
   PubMedGoogle Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• HillATCampbellEJBayleyDLHillSLStockleyRAEvidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ)Am J Respir Crit Care Med199916061968197510588615
   PubMed Web of Science ®Google Scholar
• JaroschIGehlertSJackoDDifferent training-induced skeletal muscle adaptations in COPD patients with and without alpha-1 antitrypsin deficiencyRespiration201692533934727686000
   PubMed Web of Science ®Google Scholar
• KennKGloecklRSoennichsenAPredictors of success for pulmonary rehabilitation in patients awaiting lung transplantationTransplantation20159951072107725393161
   PubMed Web of Science ®Google Scholar
• DaveyCZoumotZJordanSBronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trialLancet201538699981066107326116485
   PubMed Web of Science ®Google Scholar
• SciurbaFCCrinerGJStrangeCEffect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trialJAMA2016315202178218927179849
   PubMed Web of Science ®Google Scholar
• KotloffRMThabutGLung transplantationAm J Respir Crit Care Med2011184215917121471083
   PubMed Web of Science ®Google Scholar